Royal Bank of Canada’s Boston Scientific BSX Stock Holding History

Royal Bank of Canada’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85K	Buy	+2,000	New	+$109K	﹤0.01%	5498
2021 Q1	–	Sell	-12,000	Closed	-$431K	–	7428
2020 Q4	$431K	Hold	12,000	–	–	﹤0.01%	4261
2020 Q3	$459K	Hold	12,000	–	–	﹤0.01%	3930
2020 Q2	$421K	Hold	12,000	–	–	﹤0.01%	3924
2020 Q1	$392K	Hold	12,000	–	–	﹤0.01%	3826
2019 Q4	$543K	Sell	12,000 -30,000	-71%	-$1.26M	﹤0.01%	3922
2019 Q3	$1.71M	Sell	42,000 -5,500	-12%	-$233K	﹤0.01%	2889
2019 Q2	$2.04M	Buy	+47,500	New	+$1.83M	﹤0.01%	2752
2019 Q1	–	Sell	-900	Closed	-$32K	–	6808
2018 Q4	$32K	Buy	+900	New	+$32.6K	﹤0.01%	5337

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royal Bank of Canada's BSX Position: Q2 2026 in Review

Royal Bank of Canada increased its Boston Scientific (BSX) stake by 29% in Q2 2026, buying an estimated $99.2M and bringing the position to 8,100,653 shares worth $346M. The position accounts for 0.05% of the portfolio, ranked #316.

Royal Bank of Canada first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $753M in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Royal Bank of Canada held 8,100,653 shares of Boston Scientific worth $346M as of Q2 2026.
Royal Bank of Canada bought 1,827,390 Boston Scientific shares in Q2 2026, an estimated $99.2M.
Boston Scientific made up 0.05% of Royal Bank of Canada's portfolio in Q2 2026, its #316 holding.
Royal Bank of Canada first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
Royal Bank of Canada's Boston Scientific position peaked at $753M in Q3 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.